Shenzhen Capchem Technology (300037) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Revenue for H1 2024 reached ¥3.58 billion, up 4.35% year-over-year; net profit attributable to shareholders was ¥416 million, down 19.54% year-over-year.
Operating cash flow was negative at -¥257 million, a significant decrease from the prior year.
The company maintained its position as a leading supplier in battery chemicals, organic fluorine chemicals, capacitor chemicals, and semiconductor chemicals.
The board approved a cash dividend of ¥6 per 10 shares for 2023, with no interim dividend for H1 2024.
Major new supply agreements and overseas expansion projects were announced, supporting future growth.
Financial highlights
H1 2024 revenue: ¥3.58 billion (+4.35% YoY); net profit: ¥416 million (-19.54% YoY); EPS: ¥0.55 basic, ¥0.50 diluted.
Gross margin for the chemical segment: 27.88% (-3.07pp YoY); battery chemicals margin: 13.65% (-2.08pp YoY); organic fluorine margin: 62.22% (-10.17pp YoY); capacitor chemicals margin: 40.48% (+2.14pp YoY).
Operating cash flow: -¥257 million (vs. +¥1.61 billion YoY); total assets: ¥16.58 billion (-5.93% vs. end-2023).
R&D investment: ¥216 million (+24.98% YoY); overseas sales accounted for 25.8% of total revenue.
EBITDA/total debt: 11.04%; interest coverage: 11.02x; asset-liability ratio: 41.38%.
Outlook and guidance
Management expects continued growth in global lithium battery demand, with battery chemicals and high-end fluorine products as key drivers.
Ongoing overseas expansion (notably in Europe and the US) and new long-term supply contracts are expected to boost future revenue.
The company will focus on R&D, cost control, and operational efficiency to address margin pressure.
Latest events from Shenzhen Capchem Technology
- Q1 2026 saw revenue up 67.85% and net profit up 109.02% year-over-year.300037
Q1 202628 Apr 2026 - Revenue up 4.85%, net profit down 6.83%, strong global expansion and R&D investment.300037
Q4 202426 Dec 2025 - Q3 2025 revenue up 13.6%, net profit down 7.5%, with strong cash flow and higher R&D spend.300037
Q3 202529 Oct 2025 - H1 2025 revenue up 18.58%, net profit up 16.36%, with strong growth across all segments.300037
Q2 202526 Aug 2025 - YTD net profit fell 12% and operating cash flow turned sharply negative.300037
Q3 202413 Jun 2025 - Q1 2025 net profit surged 39% year-over-year on strong revenue growth and improved margins.300037
Q1 20256 Jun 2025